ERIN SIGLER: Open Payments
NPI 1073276564 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,089 in 107 payments from 19 companies in 2025. Trend: 2023 $1,890 · 2024 $1,547 · 2025 $2,089
Food & beverage: $1,804Education: $285
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $361 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $273 |
| ABBVIE INC. | 16 | $242 |
| Regeneron Healthcare Solutions, Inc. | 9 | $225 |
| Galderma Laboratories, L.P. | 10 | $224 |
| Novartis Pharmaceuticals Corporation | 8 | $130 |
| Lilly USA, LLC | 7 | $112 |
| UCB, Inc. | 6 | $90 |
| LEO Pharma Inc. | 4 | $66 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 4 | $65 |
Products named: TREMFYA, NEMLUVIO, DUPIXENT, SKYRIZI, ILUMYA, COSENTYX, TALTZ, Bimzelx.
Industry payments across IN — which companies pay providers there.
